A major 17-year follow up study published in the British Journal of Psychiatry [1]  found a 2.84 times  (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and  with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.

Read More